Skip to main content
. Author manuscript; available in PMC: 2012 May 16.
Published in final edited form as: Transplantation. 2011 Sep 27;92(6):678–685. doi: 10.1097/TP.0b013e31822b58be

TABLE 1.

Incidence of posttransplant complication

Complication SPK
(n=17),
n (%)		 PAK
(n=5),
n (%)		 PTA
(n=6),
n (%)		 Total
(n=28),
n (%)
Acute cellular rejection 8 (47) 1 (20) 3 (50) 12 (42)
Antibody-mediated rejection 2 (11) 0 0 2 (7)
Donor-specific antibodies 3 (17) 0 0 3 (10)
CMV 7 (41) 1 (20) 0 8 (28)
BK nephropathy 1 (6) 0 n/a 1 (5)
Bacterial infection 7 (41) 1 (20) 2 (33) 10 (36)
Neutropenia required G-CSF 5 (29) 0 1 (16) 6 (21)
PTLD 0 0 0 0

SPK, simultaneous kidney-pancreas transplantation; PAK, pancreas after kidney transplantation; PTA, pancreas transplant alone; CMV, cytomegalovirus; PTLD, posttransplant lymphoproliferative disorder.